The anticataplectic and REM suppression effect of milnacipran, an SNRI, on human and canine narcolepsy
- 1 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Sleep and Biological Rhythms
- Vol. 19 (2), 137-143
- https://doi.org/10.1007/s41105-020-00298-2
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development (JP20dm0107162)
- Japan Society for the Promotion of Science (19K08037)
This publication has 10 references indexed in Scilit:
- Pharmacologic Management of Excessive Daytime SleepinessSleep Medicine Clinics, 2020
- Serotonin neurons in the dorsal raphe mediate the anticataplectic action of orexin neurons by reducing amygdala activityProceedings of the National Academy of Sciences of the United States of America, 2017
- NarcolepsyThe New England Journal of Medicine, 2015
- Subjective and polysomnographic effects of milnacipran on sleep in depressed patientsHuman Psychopharmacology: Clinical and Experimental, 2004
- Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in ratsPsychopharmacology, 2002
- Neuropharmacology and Neurochemistry of Canine NarcolepsySleep, 1994
- Desmethyl Metabolites of Serotonergic Uptake Inhibitors Are More Potent for Suppressing Canine Cataplexy Than Their Parent CompoundsSleep, 1993
- Biochemical Effects of Antidepressants in AnimalsPublished by Springer Science and Business Media LLC ,1980
- Interactions between reserpine and various compounds on the accumulation of [14C] 5-hydroxytryptamine and [3H] noradrenaline in homogenates from rat hypothalamusBiochemical Pharmacology, 1979
- Increase of pineal noradrenaline concentration in rats by desipramine but not fluoxetine: implications concerning the specificity of these uptake inhibitorsJournal of Pharmacy and Pharmacology, 1977